Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 1;68(7):949-955.
doi: 10.1097/MAT.0000000000001586. Epub 2022 Apr 5.

Hepatic Function in Premature Lambs Supported by the Artificial Placenta and Total Parenteral Nutrition

Affiliations

Hepatic Function in Premature Lambs Supported by the Artificial Placenta and Total Parenteral Nutrition

Stephen L Harvey et al. ASAIO J. .

Abstract

The artificial placenta (AP) promotes organ development and reduces organ injury in a lamb model of extreme prematurity. This study evaluates hepatic outcomes after AP support with total parenteral nutrition (TPN) administration. Premature lambs (116-121 days estimated gestational age; term = 145) were cannulated for 7 days of AP support. Lambs received TPN with SMOFlipid (n = 7) or Intralipid (n = 5). Liver function and injury were compared between the two groups biochemically and histologically. Groups were compared by ANOVA with Tukey's multiple comparisons or linear-mixed effects models. From baseline to day 7, total bilirubin (Intralipid 2.6 ± 2.3 to 7.9 ± 4.4 mg/dl; SMOFlipid 0.3 ± 0.1 to 5.5 ± 2.3 mg/dl), alanine aminotransferase, and gamma-glutamyl transferase increased in both groups ( p < 0.001 for all). Direct bilirubin (0.3 ± 0.2 to 1.8 ± 1.4 mg/dl; p = 0.006) and AST (27 ± 5 to 309 ± 242 mg/dl; p < 0.001) increased in SMOFlipid group (not measured in Intralipid group). On liver histology, Intralipid showed more cholestasis than SMOFlipid; both groups showed more than tissue controls. The Intralipid group alone showed hepatocyte injury and had more congestion than controls. Lambs supported by the AP with TPN administration maintain normal hepatic function and sustain minimal hepatic injury. SMOFlipid is associated with decreased cholestasis and hepatic injury versus Intralipid.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to report.

Figures

Figure 1.
Figure 1.
Schematic of the artificial placenta. Blood is drained from the right jugular vein by a passive-filling roller pump and propelled to an oxygenator/heat exchanger, then returned via an umbilical vein. The second umbilical vein is accessed for intravenous fluid and medication administration, and an umbilical arterial line is placed for hemodynamic monitoring and blood gas sampling. The lamb is intubated, and the lungs remain filled with Ringer’s Lactate or perfluorodecalin. Reproduced with permission from Church et al 2018. Ao – aorta; DV – ductus venosus; IJV – internal jugular vein; IVC – inferior vena cava; RA – right atrium; SVC – superior vena cava
Figure 2.
Figure 2.
Graphs of average daily a) aspartate aminotransferase (AST), b) alanine aminotransferase (ALT), c) alkaline phosphatase (ALKP), d) gamma-glutamyl transferase (GGT), e) total bilirubin, and f) direct bilirubin for SMOFlipid® and Intralipid® groups over 7 days of artificial placenta support. Error bars represent standard deviation. P value < 0.05 considered statistically significant.
Figure 3:
Figure 3:
Mean histological liver scores for SMOFlipid®, Intralipid®, ETC and LTC for Cholestasis, Hepatocyte Injury, Congestion, Fatty Change, and EMH. Error bars represent standard deviation. P values < 0.05 considered significant.

References

    1. Myrhaug HT, Brurberg KG, Hov L, Markestad T: Survival and Impairment of Extremely Premature Infants: A Meta-analysis. Pediatrics 143 (2): e20180933, 2019. doi: 10.1542/peds.2018-0933. - DOI - PubMed
    1. Stoll BJ, Hansen NI, Bell EF, et al. : Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993–2012. JAMA 314 (10): 1039–51, 2015. doi: 10.1001/jama.2015.10244. - DOI - PMC - PubMed
    1. Laughon M, O’Shea MT, Allred EN, et al. : Chronic Lung Disease and Developmental Delay at 2 Years of Age in Children Born Before 28 Weeks’ Gestation. Pediatrics 124 (2): 637–648, 2009. doi: 10.1542/peds.2008-2874. - DOI - PMC - PubMed
    1. McGowan JE: Neonatal Hypoglycemia. Pediatr Rev 20 (7): 6e–15, 1999. doi: 10.1542/pir.20-7-e6. - DOI
    1. Pineiro-Carrero VM, Pineiro EO: Liver. Pediatrics 113 (4 Suppl): 1097–106, 2004. - PubMed

Publication types